GIA® vs. Cognivue
An FDA-cleared cognitive test on a dedicated device is one tool. Multimodal screening across 46 conditions in a conversation is another.
Cognivue Inc. offers FDA-cleared computerized cognitive assessment that runs on a dedicated Cognivue device or workstation. Patients self-administer a test lasting roughly 5 to 10 minutes, focused on cognitive function. GIA® by Scienza Health takes a different approach. She screens for 46 conditions across cognitive, behavioral, and neurological health through a natural conversation lasting 40 seconds, delivered by video, voice, or landline. During that conversation she analyzes 2,500+ Speech Biomarkers, 436 visual data points from Computer Vision, and Voice AI simultaneously. Results are prepared for clinician review and submission to the EHR.
How do they compare?
| Dimension | Cognivue | GIA™ |
|---|---|---|
| Assessment scope | Cognitive function | 46 conditions: cognitive, behavioral, neurological |
| Modality | Computerized cognitive test on dedicated device | Voice AI + Computer Vision + Speech Biomarkers |
| Delivery | On-site Cognivue device or workstation | Video, voice, or landline |
| Screening time | 5 to 10 minutes | 40 seconds |
| Staff required | Self-administered on device | Zero during screening. Clinician reviews results. |
| Speech biomarkers | None | 2,500+ per conversation |
| Clinical validation | FDA-cleared computerized cognitive assessment | Peer-reviewed speech biomarker science across 19 studies |
Where cognivue falls short
An FDA-cleared computerized cognitive assessment from Cognivue Inc., run on a dedicated Cognivue device or workstation. Patients self-administer a test lasting roughly 5 to 10 minutes, focused on cognitive function.
- Focused on cognitive function. Does not screen for depression, anxiety, PTSD, Parkinson’s, substance use, or other behavioral and neurological conditions
- Runs on a dedicated Cognivue device or workstation on site. The patient comes to the device
- Self-administered computerized test, typically 5 to 10 minutes per session
- Single test modality. No speech biomarker analysis, no computer vision, no multimodal capture
What GIA™ does differently
- Screens for 46 conditions across cognitive, behavioral, and neurological health in a single conversation (25 live, 21 coming soon)
- Multimodal: Voice AI, Computer Vision (436 visual data points), and 2,500+ Speech Biomarkers analyzed simultaneously
- 40 seconds per screening. Results delivered to the clinician in under 2 minutes
- Delivered by video, voice, or landline. No on-site device required. GIA® comes to the patient
- Zero clinical staff required during the screening conversation
- Peer-reviewed speech biomarker science across 19 published studies: cognitive decline AUC 0.890, Parkinson’s AUC 0.97
- GIA® speaks 92 languages for patient comfort and rapport
Cognivue is an FDA-cleared computerized cognitive test on a dedicated device, focused on cognitive function. GIA® by Scienza Health screens for 46 conditions across cognitive, behavioral, and neurological health through a natural conversation delivered by video, voice, or landline. If the need is a standalone cognitive test at a workstation, Cognivue serves that purpose. If the need is comprehensive multimodal screening at the point of care with no staff time and no device for the patient to operate, GIA® works in a different category. The clinician always reviews and decides.
Beyond the comparison
GIA® pairs every screening encounter with PDO — Proactive Decision Orders — a nightly EHR analysis layer that surfaces ranked clinical recommendations for physician review. No competing platform offers population-level decision support alongside point-of-care screening.
GIA® is trained on a dataset of 12.3M+ patients and 27B+ clinical records, validated across 19 peer-reviewed studies by independent researchers at academic medical centers.
Common questions
How is GIA® different from Cognivue?
Cognivue is an FDA-cleared computerized cognitive test that a patient self-administers on a dedicated device in roughly 5 to 10 minutes, focused on cognitive function. GIA® by Scienza Health screens for 46 conditions across cognitive, behavioral, and neurological health through a 40-second conversation using Voice AI, Computer Vision, and 2,500+ Speech Biomarkers. Results are prepared for clinician review.
Does GIA® require a dedicated device like Cognivue?
No. GIA® reaches the patient by video, voice, or landline. There is no workstation for the patient to travel to and no device for the patient to operate. She conducts the conversation and the clinician reviews the prepared results afterward in under two minutes.
Does Cognivue screen for depression or Parkinson’s?
Cognivue is focused on cognitive function. Behavioral and neurological conditions such as depression, anxiety, PTSD, and Parkinson’s fall outside that focus. GIA® by Scienza Health screens across all of these categories in one conversation, 46 conditions in total, and prepares the results for clinician review.
The Operator's Guide to Multimodal Clinical AI
What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.